What's breaking now, across thousands of outlets.
Lilly wagered up to $3.35 billion in its fourth China-focused alliance since January 2025. Elsewhere, analysts are now more confident about one of Vertex’s top prospects and an RNA drug succeeded against a rare form of ALS.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
The world’s largest virtual veterinary rehabilitation conference returns November 14 to explore “The Brain,” breaking down industry barriers by making the live global event completely free to join.
A study of 15,000 crash victims pinpoints the low use of helmets and the scooters’ design—built to male body proportions—as culprits
The summer of 2021 was supposed to be a joyful season of life for Mattie Quinlan: She had just gotten married and was settling down with her husband, Ryan, in Provo, Utah.
Being made to feel different, lesser or unwanted can be a common experience for many minority groups. When people are excluded or denied full social acceptance because they are perceived as having a…
Clinical decision-support tools have the potential to help clinicians make evidence-based decisions, access relevant patient information and navigate complex care.
The FDA on Sept. 22 classified the recall of one lot of Vitruvias Therapeutics' 30 mg thyroid tablets as Class I, its highest risk level
